Obstructive Cardiomyopathy Hypertrophic clinical trials

Explore recruiting obstructive cardiomyopathy hypertrophic clinical trials.

Recruiting obstructive cardiomyopathy hypertrophic studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Obstructive Cardiomyopathy Hypertrophic trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of SOtaglifloziN in symptomATic obstructive And non-obstructive Hypertrophic CardioMyopathy (SONATA-HCM)

Italy, Romania, France, Belgium, Sweden, Portugal +7 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Obstructive Cardiomyopathy Hypertrophic trials by city

Obstructive Cardiomyopathy Hypertrophic in Toronto Obstructive Cardiomyopathy Hypertrophic in Vancouver Obstructive Cardiomyopathy Hypertrophic in Montreal Obstructive Cardiomyopathy Hypertrophic in Calgary Obstructive Cardiomyopathy Hypertrophic in Edmonton Obstructive Cardiomyopathy Hypertrophic in Ottawa Obstructive Cardiomyopathy Hypertrophic in Winnipeg Obstructive Cardiomyopathy Hypertrophic in Quebec City Obstructive Cardiomyopathy Hypertrophic in Hamilton Obstructive Cardiomyopathy Hypertrophic in Kitchener Obstructive Cardiomyopathy Hypertrophic in London Obstructive Cardiomyopathy Hypertrophic in Halifax Obstructive Cardiomyopathy Hypertrophic in New York Obstructive Cardiomyopathy Hypertrophic in Los Angeles Obstructive Cardiomyopathy Hypertrophic in Chicago Obstructive Cardiomyopathy Hypertrophic in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease